Authors


Lindsey Valenzuela, PharmD

Latest:

Digital Tools Can Minimize Guesswork

Automation helps pharmacists increase their role in patient care by promoting adherence.


Diana Quach, PharmD, CGP

Latest:

Interoperability: Plugging Community Pharmacy into the Clinical Data Superhighway

In this age of emerging technology, it more important than ever for community pharmacists to get plugged into clinical data sharing.


Kayla M. Hansen, PharmD, MS, BCPS,

Latest:

Leadership and Growth Opportunities for Clinical Pharmacists

The role of lead pharmacist provides a pathway to leadership.


Nicole Kruczek, RPh, MPBA

Latest:

Easy Reading: Direct and Indirect Remuneration Fees

How a pharmacy performs with respect to specific measures can be associated with a DIR fee.





Jerika Lam, PharmD

Latest:

Pharmacists Play Role in Pharmacogenomics Clinical Services

They should consider many factors and use clear guidance on predicting phenotypes from genotypes to intervene optimally based on specific drug-gene interactions.


Marcus N. Sredzinski, PharmD

Latest:

Predictive Analytics: A Case Study in Machine-Learning and Claims Databases

A state-of-the-art predictive analysis tool that finds patients with rare diseases in a complex database could be valuable to stakeholders, who would achieve savings by helping physicians prescribe the appropriate treatment sooner.




Andrew Smith, MD Magazine

Latest:

Cutting-Edge Heart Model Predicts Changes in the Heart That Can Lead to Atrial Fibrillation

A paper from a pair of physicists may reveal significant new information about the causes of atrial fibrillation and help to make cardiac ablations a more effective treatment for the condition.



Min Gong, PharmD candidate

Latest:

Alpha-Gal (Mammalian Meat) Allergy: Implications for Pharmacists

Alpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.


Vivek Kandanati, MD

Latest:

Latent Tuberculosis After the Use of Etanercept

TNF-alpha inhibitors are used to treat a number of inflammatory conditions.


Neha Sheth Pandit, PharmD, AAHIVP, BCPS

Latest:

Hepatitis C Treatment

There are now 8 FDA approved medications for HCV treatment, all of which bypass the use of interferon.




Amitabh Gulati, MD

Latest:

Patients with Advanced Cancer: Update on Pain Management

Despite advances in pain management and palliative care, intractable cancer pain remains a significant clinical, social, and financial burden in treating the oncologic population.



John A. Szychowski, AAS, BS

Latest:

Conventional and Biologic Rheumatoid Arthritis Therapies: Utilization and Cost Trends

Based on American College of Rheumatology recommendations and novel emerging treatment options, the trend of increasing biologic use for rheumatoid arthritis is expected to continue.


Deepali Dixit, PharmD, BCPS

Latest:

A Cultural Framework Is Essential in Patient Care

Recognizing that culture is a multifaceted concept can lead to more careful and thoughtful use of the term.


Lynne Fehrenbacher, PharmD, BCPS-AQ ID

Latest:

Antibiotics That Aggravate Myasthenia Gravis

Myasthenia gravis (MG) is an autoimmune-mediated neuromuscular disease characterized by muscle weakness.



Li Gong, PhD

Latest:

The Role of Pharmacogenetics in Precision Medicine

Clinicians have long been aware that patients do not uniformly respond to medications.


Tiffany Chow, PharmD Candidate

Latest:

The Ins and Outs of the Internship Application Process

As more pharmacists graduate from pharmacy schools, landing a job has become increasingly competitive.



Aislinn Antrim, Managing Editor

Latest:

NCPA Report Outlines Potential Negative Impacts of MDPNP, Solutions

Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discusses concerns about the implementation of the MDPNP.


Marina L. Sehman, RPh, PharmD

Latest:

Trends in First-Year Utilization Costs of HIV Medications

HIV is of interest among many in managed care. This paper focuses on the costs and demographic characteristics associated with new HIV therapy initiators.


Kelly Ratliff, President of US Bioservices

Latest:

Adherence to Oral Oncolytics Requires a Clinically Integrated Approach to Specialty Pharmacy

Despite initiatives that help patients maintain adherence, health care providers still need to leverage their collective resources and work together to overcome this tremendous hurdle in cancer care.